SCM Lifescience Co., Ltd. (KOSDAQ:298060)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,114.00
-7.00 (-0.62%)
At close: Dec 5, 2025
-38.96%
Market Cap 49.24B
Revenue (ttm) 1.54B
Net Income (ttm) -8.24B
Shares Out 44.20M
EPS (ttm) -362.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 87,087
Average Volume 48,845
Open 1,121.00
Previous Close 1,121.00
Day's Range 1,085.00 - 1,177.00
52-Week Range 792.00 - 2,395.00
Beta 1.05
RSI 55.48
Earnings Date n/a

About SCM Lifescience

SCM Lifescience Co., Ltd. operates in the stem cell therapy, CMO, contract research and consulting, and cosmetic businesses. The company develops allogeneic stem cell therapeutics using its stem cell isolation technology and conducting clinical trials for immunological conditions and tissue regeneration; provides CMO services for manufacturing control and quality assurance tests; and offers adult stem cell research services. It also provides skin cell science services. The company was founded in 2014 and is headquartered in Incheon, South Korea... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 298060
Full Company Profile

Financial Performance

In 2024, SCM Lifescience's revenue was 824.80 million, an increase of 18.56% compared to the previous year's 695.70 million. Losses were -12.38 billion, -48.35% less than in 2023.

Financial Statements

News

There is no news available yet.